Predictors of overall relapse in the combined Johns Hopkins and University of Minnesota iTTP cohorts
| Variable . | HR . | 95% CI . |
|---|---|---|
| First episode/rituximab course | Reference | |
| Second rituximab course | 1.81 | 0.87-3.75 |
| Third or subsequent rituximab course | 2.47 | 1.21-5.04 |
| Black race | 1.27 | 0.63-2.60 |
| Female sex | 1.36 | 0.66-2.80 |
| Age: 18-34 y (Q1) | Reference | |
| Age: 35-45 y (Q2) | 1.14 | 0.53-2.42 |
| Age: 45-55 y (Q3) | 1.48 | 0.66-3.36 |
| Age: 56-78 y (Q4) | 1.85 | 0.76-4.50 |
| Variable . | HR . | 95% CI . |
|---|---|---|
| First episode/rituximab course | Reference | |
| Second rituximab course | 1.81 | 0.87-3.75 |
| Third or subsequent rituximab course | 2.47 | 1.21-5.04 |
| Black race | 1.27 | 0.63-2.60 |
| Female sex | 1.36 | 0.66-2.80 |
| Age: 18-34 y (Q1) | Reference | |
| Age: 35-45 y (Q2) | 1.14 | 0.53-2.42 |
| Age: 45-55 y (Q3) | 1.48 | 0.66-3.36 |
| Age: 56-78 y (Q4) | 1.85 | 0.76-4.50 |